Post on 12-Jan-2016
ASEAN COOPERATION ON HEALTH
Health and Communicable Diseases Division
ASEAN Secretariat
DAY 1 – SESSION 2: ASEAN SECRETARIAT PRESENTATION
PRESENTATION CONTENT
What is the basis of the regional cooperation on Health? What are the regional priorities in Health? What are the implementing mechanisms? What are the regional priorities of AEGCD and AWGPD?
AECBlueprint (November
2007)
ASCC Blueprint
(March 2009)
APSC Blueprint(March 2009)
2nd IAI Work Plan
(March 2009)
AEC Council ASCC Council APSC CouncilASEAN
Coordinating Council
implementation / monitoring:
ASCC: ASEAN STRATEGIC FRAMEWORK ON HEALTH DEVELOPMENT
Operationalizes the 55 health action lines of the ASCC Blueprint
Regional activities in health involve: B3. Enhancing Food Security and Safety B4. Access to healthcare and promotion of healthy lifestyle (PD
component included) B5. Improving capability to control communicable diseases (CD
component included) B7. Building disaster-resilient nations and safer communities
Xii. Promote multi-sectoral coordination and planning on PPR at the regional level including development of a regional multi-sectoral PPR plan
GUIDING PRINCIPLES - IMPLEMENTATION
Institutionalization on ASEAN Health Development
Health and Communicable Diseases Division, ASEAN Secretariat, Jakarta
FLOW OF HEALTH PROGRAMME CYCLE
IMPLEMENTATION MECHANISMS
Lead Countries Host Countries Resources from Development Partners Funds from Dialogue Partners with MOU Support from SOMHD and other working groups Collaborative, Coordinative and Facilitative Role of
ASEAN Secretariat
ASEAN EXPERT GROUP ON COMMUNICABLE DISEASES (AEGCD)_1 Initiatives started with the ASEAN Plus Three EID Program
supported by AUSAid (program concluded last June 2010) 6th AEGCD Meeting, Yangon, Myanmar: Outputs
Updated the Medium Term Plan on Emerging Infectious Diseases (MTP EID - Work Plan 2011-2015)
Endorsed the 9 components of the MTP EID for 2012-2015
Approved the Work Plans & Prioritized activities for 2012
ASEAN EXPERT GROUP ON COMMUNICABLE DISEASES (AEGCD) 6th AEGCD Meeting, Yangon, Myanmar: Outputs
Strengthened collaboration with WHO and other Development Partners
Malaria Initiatives with WHO approved; Myanmar volunteered to be lead country; Thailand to be confirmed by senior officials
Identified Regional Advocacy Initiatives
AEGCD: 9 COMPONENTS OF MTP EID ASEAN EID Mechanism (AEM), (Thailand); EID website,
(Indonesia); ASEAN Partnership Laboratories, (Malaysia) Risk Communication, (Malaysia) Human and Animal Health Collaboration, (Thailand and Lao
PDR); Operationalisation of Minimum Standards of Joint Multi-
sectoral Outbreak Investigation and Response, (Cambodia); Stockpiling of antivirals and PPE (ASEAN Secretariat), Field Epidemiology Training Network, (Thailand) WHO-EC Project on HPED particularly on cross-border
collaboration, (Thailand and Lao PDR) Specific diseases including Rabies (Viet Nam), Dengue (Viet
Nam and identified lead country for ASEAN Dengue Day), and Malaria (Myanmar, Thailand ?)
ENDORSED WORK PLANS (2012-2015) ASEAN Plus Three Partnership laboratories (APL); Risk Communication; Animal Health and Public Health Collaboration; ASEAN Emerging Infectious Diseases Mechanism (AEM)
and ASEAN EID Plus Three Website; Operationalization of Minimum Standards on Joint
Outbreak Investigation and Response; ASEAN Plus Three Field Epidemiology Training Network
(FETN); and Specific diseases including rabies and dengue with some
revisions from lead country, Viet Nam
ASEAN WORKING GROUP ON PHARMACEUTICAL DEVELOPMENT (AWGPD)
27th AWGPD Meeting, Hanoi, Viet Nam Outputs:
Finalized the Work Plan for 2012-2015Prioritized Activities for 2012Worked with AEGCD on Malaria Initiatives with focus
on Drug ResistanceStrengthened Collaborative Activities with WHOFinalized ASCC Scorecard Indicators Identified Regional Advocacy Initiatives
ASEAN Bodies related to PD
Proposed components & activities
Regional Strategies
Lead country
1) The 3rd Standard of ASEAN Herbal Medicine
Area 1 & 3 Indonesia & Thailand Proposal 2011
2) Development Programme to strengthen QA and Non-Pharmacopial Analytical Methods
Area 1 & 3 Malaysia
3) Building up & strengthening of PV
Area 1 & 2 Singapore & Thailand2012
Proposed components Regional strategies
Lead country
4) Rational Use of Drug
ASEAN – WHO Consultative Meeting on RUM, 12 July 2011
Area 2 & 3 Brunei, Singapore,
Indonesia
4.1 Workshop on Rational Use of Anti-Microbial Agents
Brunei, Singapore
4.2 ASEAN – WHO Collaborative Study on RUM in ASEAN
Singapore WHO
4.3 To conduct an ASEAN Forum on Pharmaceutical Care and its Effective Implementation in ASEAN (2013)
IndonesiaWHO
Proposed components/activities
Regional strategies
Lead countries/ $
5) Proficiency Testing Area 1 & 3 ThailandOngoing activity, donor - 2011
6) Production of ARS
• Certified Reference Material
Area I & 3 ThailandOngoing activity, donor - 2011
7) Technical cooperation with USP
Area I & 3 Thailand/USP2011
REMARKS: Activity 6 and 7 were combined: Thailand
Proposed components/activities
Regional Strategies
Lead countries/ $
8. Building up and strengthening ASEAN ‘s capacity in GCP and Clinical trial
Area 1 & 3 Thailand & Indonesia, Philippines
9) ASEAN Collaboration in combating counterfeit drug
Area 1& 2 & 3 Indonesia & LaosWHO collaboration
10) Drug resistance in malaria
Area 1 (policy advocacy)
Laos & WHO, 2011
11)Regional advocacy Area 2 ASEC, 2011
DAY 1: FEEDBACK SESSION ON THE ‘JOINT ASSESSMENT’ & ‘REGIONAL FRAMEWORK’
RELEVANT MESSAGES TO BE CONSIDERED BY ASEAN GROUPS BASED FROM THE JOINT ASSESSMENT OF THE RESPONSE TO ARTEMISININ RESISTANCE_1
Engage with the pharmaceutical sector; Enforcement of policies on counterfeit drugs
Information Sharing: Information on Drug Resistance should be shared to higher bodies in health of the region
Funding from External Sources are available but complementary support from dialogue partners can be encouraged
Cross border issues on infectious diseases should also include the concern on artemisinin-resistance
Identify main technical issues and gaps to be covered concerning artemisinin resistance and seek appropriate support from concerned partners
ASEAN Community by 2015: ASEAN has a critical role in raising political commitment and economic implications in addressing concerns relevant to issues on artemisinin resistance
RELEVANT MESSAGES TO BE CONSIDERED BY ASEAN GROUPS BASED FROM THE JOINT ASSESSMENT OF THE RESPONSE TO ARTEMISININ RESISTANCE_1
FEEDBACK: REGIONAL FRAMEWORK_1 Consider the framework to be inclusive of the ASEAN region
rather than the GMS Flexibility in the use of the funds beyond GMS to address issues
on artemisinin resistance and malarial initiatives in the region Elevate to appropriate and higher bodies the issues on malaria
initiatives and the challenge faced with artemisinin resistance with leadership from ASEAN Member States
Consider the economic impact: Elevating the issue of malaria to be one of the point of interest of the national agenda can be a concern if it is not a priority by the national government. But if we link this health issue to economic implications, then we can make this one of the priorities.
FEEDBACK: REGIONAL FRAMEWORK_2Objective 1: ASEAN has a comparative advantage in coordinating efforts on malaria initiatives Drug resistance can be placed in the context of ‘Elimination of Malaria’ Objective 2: Awareness and information sharing enhanced at the level of technical working groups initially and then to other higher bodiesObjective 3: System of monitoring can be done for malaria initiatives that is similar to MS JMOIRSupport mapping and strengthen surveillance Classify ASEAN Member States according to appropriate tiers
FEEDBACK: REGIONAL FRAMEWORK_3
Objective 5: Vector control in the context of promotion of integrated vector management (IVM) Add a narrative that this objective will complement prevention of transmission of resistant strains
FEEDBACK: REGIONAL FRAMEWORK_4Objective 6: Elevate issue of malaria concerns to the focus area of Migrants Health and Increase Access to Health Care during the workshop led by Indonesia SOMHDExplore involvement of private sector in the open sessions of the AWGPD and AEGCD meeting on matters concerning malaria
Objective 7: 7.1 consider ‘regional level’ rather the ‘GMS’ Include Economic Analysis of the impact of artemisinin resistance in the GMS and beyond
DAY 2: FOLLOW-UP/NEXT STEPS
RECOMMENDATIONS/AGREEMENTS General Comments/Agreement: Consider the following inputs
in coming up with a set of recommendations/agreements: “Facts” on Malaria by WHO is needed to level standard of
information among participants Consider the issues below that were discussed in Day 1:
Contextualized in the elimination of malaria Migration issues Cross-border issues Economic implications
Workshop Document should contain the following: I. Background
Facts WHA Resolution 2007
II. Challenges III. Key Recommendation IV. Way Forward
RECOMMENDATIONS/AGREEMENTS I. Background
Facts WHA Resolution 2007
II. Challenges (NOTE: for ranking) Awareness (community, border to decision level) Lack of cross sectoral interaction Access and quality of medicines/ Stock outs Migrants Health and Cross-border concerns Illegal trade across countries/ smuggling Economic implications Resource gap Limited alternative medicines Implications of rapid economic development to health situation
including the issue of re-emerging diseases (malaria in particular) Global Warming (?)
III. Key Recommendation IV. Way Forward
WHA: ASEAN sideline meetings (exchange) leaflets
RECOMMENDATIONS/AGREEMENTS III. Key Recommendation (NOTE: for ranking)
Ensure effectiveness of ACTs Every member state to monitor therapeutic efficacy of medicines Removal of artermisinin monotherapy (import, ban of production
and export) Standardization of quality of ACT Private sector involvement
Strengthen regional cooperation on regulations and monitoring of cross-border concerns such as trade of pharmaceuticals, migrants issues Assessment of impact of the disease burden as it relates to
economic implications Involvement also of the private sector and research Focus on migrants health and mobile populations Common regional regulatory framework on medicines Ensure bilateral cooperation will take into account regional
cooperation/agreements
RECOMMENDATIONS/AGREEMENTS III. Key Recommendation (NOTE: for ranking)
Ensure initiatives on elimination of malaria be included in the regional priorities of ASEAN subsidiary bodies Lead countries of concerned subsidiary bodies on AWGPD and
AEGCD to proposed work plan activities relevant to malaria initiatives
Relevant subsidiary bodies within ASEAN will also be involved in cross-sectoral collaborative activities
Strategy to strengthen prevention and control to reduce transmission
Strategy to maintain free malaria status Ensure adequate resources for the elimination of malaria
including artemisinin resistance Involvement also of the private sector
NEXT STEPS
WHO to finalize the workshop document – 2 weeks Circulate the workshop document to participants of the
workshop – 2 weeks Seek concurrence from the appropriate ASEAN health
subsidiary bodies (ie. AEGCD, AWGPD) – within May/June 2012
Elevate recommendations of AEGCD and AWGPD to SOMHD – within May/June 2012
SOMHD recommendations to be elevated to AHMM – within June 2012